Clinical Evaluation for Post Bleaching Hypersensitivity Using Desensitizing Agent During In-office Bleaching
NCT ID: NCT02942082
Last Updated: 2019-09-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
36 participants
INTERVENTIONAL
2017-11-01
2018-11-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Resin-Based Desensitizer and Laser, Compared to Fluoride Varnish in Management of Dentine Hypersensitivity in Non-carious Cervical Lesions
NCT07113847
Desensitizing Effect and Tooth Color Change After Using Giomer-based Varnish Versus Bioactive Glass Air Polishing in Treating Cervical Hypersensitive Lesions
NCT05981625
Clinical Evaluation of Giomer Based Varnish Versus CPP-ACP Varnish in the Management of Dentin Hypersensitivity: a Randomized Clinical Trial
NCT06154941
Treatment of Dentin Hypersensitivity Using Different Desensitizing Agents
NCT04340869
Staining Potential and Caries Arresting Effect of Silver Diamine Fluoride⁄Potassium Iodide and Silver Diamine Fluoride
NCT04196829
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ACP oral care geldesensitizing agent
a desensitizing agent will be applied on tooth before and /or after bleaching.
ACP oral care gel
a desensitizing agent will be applied on tooth before and/or after bleaching
glycrin
glycrin will be applied on tooth before and /or after bleaching.
glycrin
glycrin will be applied on tooth surface before and/or after bleaching
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ACP oral care gel
a desensitizing agent will be applied on tooth before and/or after bleaching
glycrin
glycrin will be applied on tooth surface before and/or after bleaching
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male or female patients between the ages of 18 to 40.
* Patients with good general and oral health.
* Patients having six caries-free maxillaryanterior teeth without restorations on the labial surfaces.
* Patients should have central incisors determined to be shade C2 or darker
Exclusion Criteria
* Patient with anterior restorations or non carious cervical lesion.
* Patient having severe internal tooth discoloration (tetracycline stains, fluorosis, pulpless teeth), and bruxism habits.
* Tempro-mandibular joint problems involving symptomatic pain.
* Patients taking analgesics that could alter their normal pain perception level.
* Pregnant or breast feeding women.
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Silvia Sabry
researcher
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of dentistry Cairo university
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CEBD-CU-2016-10-222
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.